Omega Healthcare Investors, Inc. (BVMF:O2HI34)
Brazil · Delayed Price · Currency is BRL | Market Cap | 73.41B +16.8% |
| Revenue (ttm) | 6.45B +14.0% |
| Net Income | 3.21B +41.1% |
| EPS | 10.76 +29.0% |
| Shares Out | n/a |
| PE Ratio | 22.85 |
| Forward PE | 23.18 |
| Dividend | 3.16 (3.93%) |
| Ex-Dividend Date | Apr 30, 2026 |
| Volume | 15 |
| Average Volume | 1 |
| Open | 81.20 |
| Previous Close | n/a |
| Day's Range | 80.56 - 81.20 |
| 52-Week Range | 66.01 - 85.05 |
| Beta | 0.59 |
| RSI | 77.95 |
| Earnings Date | Apr 28, 2026 |
About BVMF:O2HI34
Omega Healthcare Investors, Inc. is a Real Estate Investment Trust. The firm is providing financing and capital to the long-term healthcare industry in the United States and the United Kingdom with a focus on skilled nursing and assisted living facilities, including care homes in the United Kingdom. As of September 30, 2025, Omega has a portfolio of investments that includes 1,024 operating facilities located in 42 states, the District of Columbia and the United Kingdom/Jersey (290 facilities) and operated by 88 different operators. Additionall... [Read more]
Financial Performance
In 2025, BVMF:O2HI34's revenue was $1.19 billion, an increase of 13.19% compared to the previous year's $1.05 billion. Earnings were $572.03 million, an increase of 40.78%.
Financial numbers in USD Financial StatementsNews
Omega Healthcare price target raised to $54 from $52 at UBS
UBS raised the firm’s price target on Omega Healthcare (OHI) to $54 from $52 and keeps a Buy rating on the shares.
Omega Healthcare price target raised to $52 from $50 at BMO Capital
BMO Capital raised the firm’s price target on Omega Healthcare (OHI) to $52 from $50 and keeps a Market Perform rating on the shares as part of a broader research…
Omega Healthcare price target raised to $48 from $47 at RBC Capital
RBC Capital raised the firm’s price target on Omega Healthcare (OHI) to $48 from $47 and keeps a Sector Perform rating on the shares. The company delivered a healthy earnings…
Omega Healthcare price target raised to $52 from $50 at Citi
Citi analyst Nick Joseph raised the firm’s price target on Omega Healthcare (OHI) to $52 from $50 and keeps a Buy rating on the shares.
Omega Healthcare Investors Earnings Call Transcript: Q1 2026
Q1 2026 saw strong AFFO and FAD growth, driven by acquisitions and active portfolio management, with a robust investment pipeline and competitive market conditions. Asset sales and redeployment are expected to further boost earnings, while guidance was raised for the year.
Omega Healthcare Investors Earnings release: Q1 2026
Omega Healthcare Investors released its Q1 2026 earnings on April 29, 2026, summarizing the period's financial results.
Omega Healthcare Investors Quarterly report: Q1 2026
Omega Healthcare Investors has published its Q1 2026 quarterly earnings report on April 29, 2026.
Omega Reports First Quarter 2026 Results and Recent Developments
HUNT VALLEY, Md.--(BUSINESS WIRE)---- $OHI #Healthcare--Omega Healthcare Investors, Inc. (NYSE: OHI) (the “Company” or “Omega”) announced today its results for the quarter ended March 31, 2026. FIRST ...
Omega Announces Quarterly Dividend
HUNT VALLEY, Md.--(BUSINESS WIRE)---- $OHI #Healthcare--Omega Healthcare Investors, Inc. (NYSE:OHI) today announced that the Company's Board of Directors declared a cash dividend of $0.67 per share on...
Omega Healthcare Investors Proxy statement: Proxy filing
Omega Healthcare Investors filed a proxy statement on April 21, 2026, providing details for shareholder voting and corporate governance matters.
Omega Healthcare Investors Proxy statement: Proxy filing
Omega Healthcare Investors filed a proxy statement on April 21, 2026, providing details for shareholder voting and corporate governance matters.
Omega Healthcare downgraded to Underperform from Neutral at BofA
BofA downgraded Omega Healthcare (OHI) to Underperform from Neutral with a price target of $46, down from $52. The firm is reducing its FY26 AFFO estimate inline with the Street…
3 Healthcare Stocks Providing Relief for the Sandwich Generation
According to AARP, about 59 million Americans provided care for an adult family member, neighbor, or friend in 2024. That totaled 49.5 billion hours of care at a cost of around $1.01 trillion in annua...
Omega Announces First Quarter Earnings Release Date and Conference Call
HUNT VALLEY, Md.--(BUSINESS WIRE)--Omega Healthcare Investors, Inc. (NYSE:OHI) announced today that it is scheduled to release its earnings results for the quarter ended March 31, 2026, on Tuesday, Ap...
Omega Healthcare price target raised to $47 from $45 at Wells Fargo
Wells Fargo raised the firm’s price target on Omega Healthcare (OHI) to $47 from $45 and keeps an Equal Weight rating on the shares. The firm continues to view Senior…
Omega Healthcare price target raised to $48 from $46 at Truist
Truist analyst Michael Lewis raised the firm’s price target on Omega Healthcare (OHI) to $48 from $46 and keeps a Hold rating on the shares. The fundamentals are at the…
Omega Healthcare price target raised to $48 from $45 at Scotiabank
Scotiabank analyst Nicholas Yulico raised the firm’s price target on Omega Healthcare (OHI) to $48 from $45 and keeps a Sector Perform rating on the shares. The firm is updating…
High Yield Revival: 3 Cash-Rich Dividend Payers on Sale
Investors aren't putting cash under their mattresses, but they're certainly looking to take some risk off the table. This means rotation out of high-growth technology stocks and looking for value.
Omega Healthcare price target raised to $47 from $44 at RBC Capital
RBC Capital raised the firm’s price target on Omega Healthcare (OHI) to $47 from $44 and keeps a Sector Perform rating on the shares. The company delivered a healthy report…
Omega Healthcare price target raised to $52 from $50 at Cantor Fitzgerald
Cantor Fitzgerald raised the firm’s price target on Omega Healthcare (OHI) to $52 from $50 and keeps an Overweight rating on the shares. Omega Healthcare delivered strong external growth and…
Omega Healthcare price target raised to $52 from $51 at UBS
UBS raised the firm’s price target on Omega Healthcare (OHI) to $52 from $51 and keeps a Buy rating on the shares.
Omega Healthcare Investors Earnings Call Transcript: Q4 2025
Fourth quarter results showed strong revenue and earnings growth, driven by acquisitions and portfolio management, with AFFO and FAD both up over 8% year-over-year. The balance sheet was strengthened through significant debt reduction and new investments, while 2026 guidance projects continued growth and robust liquidity.
Omega Healthcare Investors Annual report: Q4 2025
Omega Healthcare Investors has published its Q4 2025 annual report on February 5, 2026.
Omega Healthcare Investors Earnings release: Q4 2025
Omega Healthcare Investors released its Q4 2025 earnings on February 5, 2026, summarizing the period's financial results.
Omega Healthcare Investors Annual report: Q4 2025
Omega Healthcare Investors has published its Q4 2025 annual report on February 5, 2026.